Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing?

To examine the prescribing of prochlorperazine secondary to the prescribing of a medicine which could lead to symptoms for which prochlorperazine is indicated and commonly used. Given the range of potential hypotensive, sedative, dystonic and other extra‐pyramidal side effects associated with prochlorperazine, its association with hip fracture was also examined.

[1]  J. Pasco,et al.  Age- and Gender-Specific Rate of Fractures in Australia: A Population-Based Study , 1999, Osteoporosis International.

[2]  Jerry H Gurwitz,et al.  Optimising drug treatment for elderly people: the prescribing cascade , 1997, BMJ.

[3]  H. Krumholz,et al.  Adverse effects of beta-blocker therapy for patients with heart failure: a quantitative overview of randomized trials. , 2004, Archives of internal medicine.

[4]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.

[5]  J. Hallas,et al.  Drug‐induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions , 2000, Alimentary pharmacology & therapeutics.

[6]  L. Blizzard,et al.  Statin therapy, muscle function and falls risk in community-dwelling older adults. , 2009, QJM : monthly journal of the Association of Physicians.

[7]  Michael A Miller,et al.  Randomized evaluation of octreotide vs prochlorperazine for ED treatment of migraine headache. , 2009, The American journal of emergency medicine.

[8]  Brämer Gr.  International statistical classification of diseases and related health problems. Tenth revision. , 1988, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[9]  Kerrie M. Sanders,et al.  The human cost of fracture , 2005, Osteoporosis International.

[10]  M. Kochen,et al.  Drug changes at the interface between primary and secondary care. , 2004, International journal of clinical pharmacology and therapeutics.

[11]  C. Coffey,et al.  Adverse effects of -blocker therapy for patients with heart failure: A quantitative overview of ran , 2004 .

[12]  J. Armitage,et al.  The safety of statins in clinical practice , 2007, The Lancet.

[13]  D. Vinson,et al.  Prochlorperazine induces akathisia in emergency patients. , 1999, Annals of emergency medicine.

[14]  J. Hallas.  Evidence of Depression Provoked by Cardiovascular Medication: A Prescription Sequence Symmetry Analysis , 1996, Epidemiology.

[15]  G. McLean.  Pharmacology, 5th edn , 2004 .

[16]  G Lindberg,et al.  Cholesterol‐lowering drugs and antidepressants—A study of prescription symmetry , 1998, Pharmacoepidemiology and drug safety.

[17]  B. Kernot.  Prescribing in older people. , 2004, Australian family physician.

[18]  U. Braun,et al.  High prevalence of orthostatic hypotension and its correlation with potentially causative medications among elderly veterans , 2005, Journal of clinical pharmacy and therapeutics.

[19]  Jesper Hallas,et al.  Statins and nonsteroidal anti‐inflammatory drugs—an analysis of prescription symmetry , 2006, Pharmacoepidemiology and drug safety.

[20]  Profess Ional Relat,et al.  National Centre for Classification in Health , 2001 .

[21]  C. Cooper,et al.  Antipsychotic use and the risk of hip/femur fracture: a population-based case–control study , 2009, Osteoporosis International.

[22]  Wilbert S. Aronow,et al.  Treating Hypertension in Older Adults , 2009, Drug safety.

[23]  Jesper Hallas,et al.  Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis , 2009, Pharmacoepidemiology and drug safety.

[24]  J. Geweke,et al.  The aftermath of hip fracture: discharge placement, functional status change, and mortality. , 2009, American journal of epidemiology.